Ainos

Capital allocation shows red flags for quality investors. The company relies on related‑party funding via convertible notes and a short‑term loan from ASE affiliates, issued at 6% compounded interest with conversion prices subject to anti‑dilution adjustments.

Share-based compensation and one‑time special stock bonuses were material in 2024–2025, and shares outstanding rose to 7.38 million by June 30, 2026 due to RSU deliveries, ATM issuance, and other grants.

While investments in platform R&D and channel partnerships may be strategically sensible, the combination of heavy dilution, thin cash cushion, and going‑concern disclosure indicates poor optionality for shareholders until profitable recurring revenue arrives.